Consolidated Statements of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2012		Jun. 30, 2011		Jun. 30, 2010
Income Statement [Abstract]
Revenue	$ 107,552		$ 102,644		$ 98,503
Cost of products sold	103,011		98,482		94,722
Gross margin	4,541		4,162		3,781
Operating expenses:
Distribution, selling, general and administrative expenses	2,677		2,528		2,397
Restructuring and employee severance	21	[1]	15	[1]	91	[1]
Acquisition-related costs	33		90		19
Impairments and loss on disposal of assets	21		9		29
Litigation (recoveries)/charges, net	(3)		6		(62)
Operating earnings	1,792		1,514		1,307
Other (income)/expense, net	(1)		(22)		(13)
Interest expense, net	95		93		113
Loss on extinguishment of debt	0		0		40
Gain on sale of investment in CareFusion	0		(75)		(45)
Earnings before income taxes and discontinued operations	1,698		1,518		1,212
Provision for income taxes	628		552		625
Earnings from continuing operations	1,070		966		587
Earnings/(loss) from discontinued operations, net of tax	(1)		(7)		55
Net earnings	$ 1,069		$ 959		$ 642
Basic earnings/(loss) per Common Share:
Continuing operations (per share)	$ 3.10		$ 2.77		$ 1.64
Discontinued operations	$ 0.00		$ (0.02)		$ 0.15
Net basic earnings per Common Share	$ 3.10		$ 2.75		$ 1.79
Diluted earnings/(loss) per Common Share:
Continuing operations (per share)	$ 3.06		$ 2.74		$ 1.62
Discontinued operations	$ 0.00		$ (0.02)		$ 0.15
Net diluted earnings per Common Share	$ 3.06		$ 2.72		$ 1.77
Weighted average number of Common Shares outstanding:
Weighted-average Common Shares-basic	345		349		359
Weighted-average Common Shares-diluted	349		353		361

[1] (3)We incurred restructuring expenses related to the Spin-Off of $7 million and $65 million for fiscal 2011 and 2010, respectively.